Clinical Trials: Anti adhesion agent

From http://ClinicalTrials.gov

Found 27 studies with search of:
Anti adhesion agent

1
Recruiting
Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil
Condition:
Bilateral Ovarian Disease
Intervention:
Biological: Anti adhesion agent
2
Completed
Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions
Condition:
Intraperitoneal Adhesions
Intervention:
Biological: Anti-Adhesion Product
3
Active, not recruiting
The Effects of Cranberry Juice on Bacterial Adhesion
Conditions:
Bacterial Vaginosis; Oxaluria
Intervention:
Procedure: cranberry juice
4
Active, not recruiting
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
Conditions:
Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; X-Linked Agammaglobulinemia; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; X-Linked Hyper IgM Syndrome; Severe Combined Immunodeficiency; Leukocyte Adhesion Deficiency Syndrome; Virus-Associated Hemophagocytic Syndrome
Interventions:
Drug: anti-thymocyte globulin; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: etoposide; Drug: methotrexate; Drug: methylprednisolone; Drug: prednisone; Procedure: Allogeneic Bone Marrow Transplantation
5
Active, not recruiting
The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
Conditions:
Arteriosclerosis; Stress, Psychological
Intervention:
Drug: inderal (drug), acetylsalicylic acid (drug)
6
Completed
Evaluation of Adhesion and Dermal Tolerability of EMSAM
Condition:
Healthy
Interventions:
Drug: EMSAM (Selegiline Transdermal System) 6mg/24Hr; Drug: EMSAM (Selegiline Transdermal System) 9mg/24Hr; Drug: EMSAM (Selegiline Transdermal System) 12mg/24hr
7
Recruiting
Efalizumab to Treat Uveitis
Conditions:
Uveitis; Intraocular Inflammatory Diseases
Intervention:
Drug: Raptiva (efalizumab)
8
Completed
Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
Condition:
Leukocyte Adhesion Deficiency Syndrome
Intervention:
Drug: Interferon gamma
9
Not yet recruiting
Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.
Conditions:
Diabetes Mellitus; Hypertension
Interventions:
Drug: atrorvastatin 10mg; Drug: simvastatin 40mg
10
Recruiting
Raptiva to Treat Sjogren's Syndrome
Condition:
Sjogren's Syndrome
Intervention:
Drug: Raptiva
11
Recruiting
Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
Conditions:
Metabolic Syndrome; Oxidative Stress; Inflammation
Intervention:
Drug: pitavastatin
12
Completed
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Conditions:
Hypercholesterolemia; Postmenopause
Interventions:
Drug: L-arginine; Drug: Estrogen
13
Completed
A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
Condition:
Cancer
Intervention:
Drug: Genistein
14
Recruiting
Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Conditions:
MUD Transplant; AlloPBSC; Congenital Immunodeficiencies; HLA Matched Transplant; BMT
Interventions:
Drug: Busulfan; Drug: Campath-1 H; Drug: Sirolimus; Procedure: BMT; Procedure: Apheresis; Procedure: Total Body Irradiation; Procedure: GCSF Injections
15
Suspended
Phase III Randomized Trial of Thalidomide/Dexamethasone vs VAD.
Condition:
Multiple Myeloma
Interventions:
Drug: thalidomide; Drug: dexamethasone; Drug: vincristine; Drug: doxorubicin; Drug: zoledronic acid
16
Recruiting
Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease
Condition:
Anemia, Sickle Cell
Interventions:
Drug: Dexamethasone; Drug: Placebo
17
Not yet recruiting
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
Condition:
Coronary Artery Disease
Intervention:
Drug: rosiglitazone/metformin
18
Recruiting
A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations
Condition:
Pulmonary Disease, Chronic Obstructive
Intervention:
Drug: fluticasone and salmeterol
19
Recruiting
Study of the Inflammatory Activity in Diabetic Patients With Stable Angina Treated With Simvastatin and Ezetimibe
Conditions:
Diabetes; Stable Angina
Intervention:
Drug: simvastatin or ezetimibe/simvastatin, 6 weeks
20
Recruiting
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
Condition:
Coronary Heart Disease
Intervention:
Drug: montelukast
21
Completed
GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes
Condition:
Type 2 Diabetes
Intervention:
Drug: Tesaglitazar
22
Completed
Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
Condition:
HIV Infections
Intervention:
Drug: miconazole Lauriad
23
Active, not recruiting
Non-Traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes
Condition:
Type 2 Diabetes Mellitus
Interventions:
Drug: Insulin; Drug: Glimepiride; Drug: Rosiglitazone; Drug: Metformin
24
Terminated
N-Acetylcysteine and Arginine Administration in Diabetic Patients
Conditions:
Type 2 Diabetes Mellitus; Hypertension
Interventions:
Drug: Arginine; Drug: Acetylcysteine; Drug: Placebo
25
Completed
GALLANT 7 Tesaglitazar Add-on to Sulphonylurea
Condition:
Type 2 Diabetes
Interventions:
Drug: Tesaglitazar 0.5 or 1 mg; Drug: Glibenclamide 2.5, 5, 10 or 15 mg
26
Completed
GALLANT 4 Tesaglitazar vs. Glibenclamide
Condition:
Type 2 Diabetes
Interventions:
Drug: Tesaglitazar; Drug: Glibenclamide
27
Recruiting
A Safety Study of Two Intratumour Doses of Coxsackievirus Type A21 in Melanoma Patients.
Condition:
Stage IV Melanoma
Intervention:
Drug: Coxsackievirus A21